Glenmark Pharmaceuticals reports consolidated net profit of Rs 171.48 crore in Q4

13 May 2016 Evaluate

Glenmark Pharmaceuticals has reported results for the fourth quarter and year ended March 31, 2016.

The company has posted a fall of 24.27% in its net profit at Rs 507.75 crore for the quarter ended March 31, 2016 as compared to Rs 670.43 crore for the same quarter in the previous year. Total income of the company has decreased by 37.53% at Rs 1972.67 crore for quarter under review as compared to Rs 3157.79 crore for the quarter ended March 31, 2015.

On consolidated basis, the company has posted a net profit after taxes, minority interest and share of profit of associates of Rs 171.48 crore for the quarter ended March 31, 2016. Total income of the company stood at Rs 2292.94 crore for the quarter ended March 31, 2016.

For the year ended March 31, 2016, the company has posted a rise of 45.75% in its net profit at Rs 1468.43 crore as compared to Rs 1007.52 crore for the same period in the previous year. Total income of company increased by 20.51% at Rs 6230.78 crore for year under review as compared to Rs 5170.54 crore for the period ended March 31, 2015.  

For the year ended March 31, 2016, on the consolidated basis, the company has posted a net profit after taxes, minority interest and share of profit of associates of Rs 720.10 crore. Total income of the company stood at Rs 7579.99 crore for the year ended March 31, 2016. 

Glenmark Pharma Share Price

2022.95 -12.95 (-0.64%)
01-Jan-2026 09:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.00
Dr. Reddys Lab 1253.30
Cipla 1501.30
Zydus Lifesciences 909.00
Lupin 2092.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×